[Tests at the Forlanini Institute of combined antibiotic therapy of early forms of pulmonary tuberculosis, with special reference to combined streptomycin-isoniazid].
D000900:Anti-Bacterial Agents; D007538:Isoniazid; D009525:Niacin; D009539:Nicotinic Acids / Q000627:therapeutic use*; D013307:Streptomycin / Q000627:therapeutic use*; D014376:Tuberculosis; D014397:Tuberculosis, Pulmonary / Q000628:therapy*
D000900:Anti-Bacterial Agents; D009539:Nicotinic Acids; D009525:Niacin; D007538:Isoniazid; D013307:Streptomycin
NICOTINIC ACID ISOMERS/therapeutic use; STREPTOMYCIN/therapeutic use; TUBERCULOSIS, PULMONARY/therapy
L'esperienza dell'Instituto Forlanini sulla terapia antibiotica combinata nelle forme recenti di tubercolosi polmonare con particolare riguardo all'associazione streptomicina-isoniazide.